In addition, a study has demonstrated that the inclusion of prevalent cases in a population-based epidemiological cohort of breast cancer patients does not bias the hazard ratio estimation for three prognostic factors—clinical stage, grade and estrogen receptor status in a left truncation Cox survival analysis when the proportional hazards assumption holds [32]. This evidence concerns the gene ESR1 and breast cancer.